Gennari R, Curigliano G, Rotmensz N, et al. Breast carcinoma in elderly women: features of disease presentation, choice of local and systemic treatments compared with younger post-menopasual patients. Cancer. 2004;101:1302–10.
PubMed
Article
Google Scholar
Colleoni M, Rotmensz N, Robertson C, et al. Very young women (<35 years) with operable breast cancer: features of disease at presentation. Ann Oncol. 2002;13:273–9.
CAS
PubMed
Article
Google Scholar
Muss HB, Woolf S, Berry D, et al. Adjuvant chemotherapy in older and younger women with lymph node-positive breast cancer. JAMA. 2005;293(9):1073–81.
CAS
PubMed
Article
Google Scholar
Mise M, Higashide S, Hashimoto K, et al. Clinicopathological features of young patients with triple negative breast cancer. Gan To Kagaku Ryoho. 2009;36(10):1677–81.
Han W, Kim SW, Park IA, et al. Young age: an independent risk factor for disease-free survival in women with operable breast cancer. BMC Cancer. 2004;4:82.
Schonberg MA, Marcantonio ER, Li D, et al. Breast cancer among the oldest old: tumor characteristics, treatment choices, and survival. J Clin Oncol. 2010;28(12):2038–45.
PubMed Central
PubMed
Article
Google Scholar
Du X, Goodwin JS. Patterns of use of chemotherapy for breast cancer in older women: findings from Medicareclaims data. J Clin Oncol. 2001;19(5):1455–61.
CAS
PubMed
Google Scholar
Cancello G, Maisonneuve P, Rotmensz N, et al. Prognosis and adjuvant treatment effects in selected breast cancer subtypes of very young women (<35 years) with operable breast cancer. Ann Oncol. 2010;21:1974–81.
CAS
PubMed
Article
Google Scholar
Ring A, Sestak I, Baum M, et al. Influence of comorbidities and age on risk of death without recurrence: a retrospective analysis of the arimidex, tamoxifen alone orin combination trial. J Clin Oncol. 2011;1029(32):4266–72.
Article
Google Scholar
Rapiti E, Fioretta G, Verkooijen HM, et al. Survival of young and older breast cancer patients in Geneva from 1990 to 2001. Eur J Cancer. 2005;41:1446–52.
PubMed
Article
Google Scholar
Bauer KR, Brown M, Cress RD, et al. Descriptive analysis of estrogen receptor (ER)-negative, progesterone receptor (PR)-negative, and HER2-negative invasive breast cancer, the so-called triple-negative phenotype: a population-based study from the California cancer Registry. Cancer. 2007;109:1721–8.
PubMed
Article
Google Scholar
Carey LA, Perou CM, Livasy CA, et al. Race, breast cancer subtypes, and survival in the Carolina Breast Cancer Study. JAMA. 2006;295:2492–502.
CAS
PubMed
Article
Google Scholar
Foulkes WD, Smith IE, Reis-Filho JS. Triple negative breast cancer. N Engl J Med. 2010;363(20):1938–48.
CAS
PubMed
Article
Google Scholar
Dent R, Trudeau M, Pritchard KI, et al. Triple-negative breast cancer: clinical features and patterns of recurrence. Clin Cancer Res. 2007;13(15 Pt 1):4429–34.
PubMed
Article
Google Scholar
Yang MT, Rong TH, Huang ZF, et al. Clinical analysis of resectable breast cancer: a report of 6 263 cases. Ai Zheng. 2005;24:327–31.
PubMed
Google Scholar
Han W. Kang SY: relationship between age at diagnosis and outcome of premenopausal breast cancer: age less than 35 years is a reasonable cut-off for defining young age-onset breast cancer. Breast Cancer Res Treat. 2010;119:193–200.
PubMed
Article
Google Scholar
Goldhirsch A, Ingle JN, Gelber RD, et al. Thresholds for therapies: highlights of the St Gallen International Expert Consensus on the primary therapy of early breast cancer 2009. Ann Oncol. 2009;20:1319–29.
CAS
PubMed Central
PubMed
Article
Google Scholar
Walker RA, Lees E, Webb MB, et al. Breast carcinomas occurring in young women (<35 years) are different. Br J Cancer. 1996;74:1796–800.
CAS
PubMed Central
PubMed
Article
Google Scholar
Chung M, Chang HR, Bland KI, et al. Younger women with breast carcinoma have a poorer prognosis than older women. Cancer. 1996;77:97–103.
CAS
PubMed
Article
Google Scholar
Winchester DP, Osteen RT, Menck HR. The national cancer data base report on breast carcinoma characteristics and outcome in relation to age. Cancer. 1996;78:1838–43.
CAS
PubMed
Article
Google Scholar
Iwase H, Kurebayashi J, Tsuda H, et al. Clinicopathological analyses of triple negative breast cancer using surveillance data from the Registration Committee of the Japanese Breast Cancer Society. Breast Cancer. 2010;17:118–24.
PubMed
Article
Google Scholar
Rodríguez-Pinilla SM, Sarrió D, Honrado E, et al. Prognostic significance of basal-like phenotype and fascin expression in node negative invasive breast carcinomas. Clin Cancer Res. 2006;12(5):1533–9.
PubMed
Article
Google Scholar
Nielsen TO, Hsu FD, Jensen K, et al. Immunohistochemical and clinical characterization of the basal-like subtype of invasive breast carcinoma. Clin Cancer Res. 2004;10:5367–74.
CAS
PubMed
Article
Google Scholar
Konigsberg R, Pfeiler G, Klement T, et al. Tumor characteristics and recurrence patterns in triple negative breast cancer: a comparison between younger (<65) and elderly (P65) patients. Eur J Cancer. 2012.